Skip to main
PLXS
PLXS logo

Plexus (PLXS) Stock Forecast & Price Target

Plexus (PLXS) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 15%
Hold 46%
Sell 8%
Strong Sell 0%

Bulls say

Plexus Corp demonstrated a strong financial performance with a 15% year-over-year increase in new program wins in the Healthcare/Life Sciences segment, amounting to $130 million. The company's return on invested capital (ROIC) improved to 13.8%, up from 11.8% quarter-over-quarter, highlighting effective management of investments. Additionally, Plexus reported a significant turnaround in free cash flow, reaching $27 million compared to a negative $32 million in the prior year, and has raised its FY25 free cash flow outlook to $100 million, indicating robust future financial health.

Bears say

Plexus Corp experienced a decline in overall revenue, with a 1% year-over-year decrease to $976 million, falling short of previous guidance and market expectations. The company's guidance for FQ2 indicates stagnation in revenue growth, with a significant anticipated decline in the Industrial sector which cannot be compensated by gains in SemiCap. Additionally, free cash flow dropped substantially from $194 million in FQ4 to $27 million in FQ1, raising concerns about the company's financial performance and sustainability.

Plexus (PLXS) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 15% recommend Buy, 46% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Plexus (PLXS) Forecast

Analysts have given Plexus (PLXS) a Buy based on their latest research and market trends.

According to 13 analysts, Plexus (PLXS) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $95.77, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $95.77, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Plexus (PLXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.